We believe it will be useful for clinicians to use neutrophil/lymphocyte ratio above 7.4 and urea/albumin ratio above 0.28, (ALP × ALT)/albumin index above 238 being (specific to the Caucasian group ) as indicators of severity and consider appropriate intervention to reduce mortality in COVID‐19. The gene discussed is GPT; the disease is COVID-19.